Anavex Life Sciences Corp (AVXL): Answering that simple question seems to...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	34
Posts	4311
Boards Moderated	0
Alias Born	07/16/2014

F1ash

Re: Steady_T post# 183581

Sunday, 03/03/2019 6:59:14 PM

Sunday, March 03, 2019 6:59:14 PM

Answering that simple question seems to require a bit of sleuthing and still requires an educated guess.

From the Australian registration for AD

Treatment: Drugs - High dose ANAVEX2-73
Treatment: Drugs - Mid dose ANAVEX2-73
Treatment: Drugs - Placebo oral capsule

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=17993&isClinicalTrial=True

For the PDD study

ANAVEX2-73 Study in Parkinson's Disease Dementia

Drug: High dose ANAVEX2-73
Drug: Mid dose ANAVEX2-73
Drug: Placebo oral capsule

https://clinicaltrials.gov/ct2/show/NCT03774459?term=Anavex&rank=2

What the high and low dose actually represent for the EU PDD trial

Concentration unit mg milligram(s)

Concentration number 10
Concentration number 20

https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004335-36/ES

Are they only administering 10 and 20 mgs as the High and Mid dose in the AD trial?